TGFB2 and glaucoma: Our results indicate that serum TGF-β2 is not a valuable biomarker for glaucoma screening and confirm local ocular production of TGF-β2, with the ciliary and lens epithelia as major sources of TGF-β2 in the AH and anterior segment tissues.